ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 251

$363K Total Retail Price of All Prescriptions

Rank: 44 out of 251

469 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 4,946 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
ATENOLOL 430 321 1 12
SIMVASTATIN 365 279 2 1
LISINOPRIL 336 293 3 2
METFORMIN HCL 294 177 4 10
LEVOTHYROXINE SODIUM 207 130 5 3
GLIPIZIDE 190 154 6 56
FUROSEMIDE 187 145 7 6
ATENOLOL-CHLORTHALIDONE 173 137 8 135
CITALOPRAM HBR 155 61 9 15
METOPROLOL TARTRATE 148 120 10 7
PRAVASTATIN SODIUM 142 113 11 14
OMEPRAZOLE 132 48 12 5
PANTOPRAZOLE SODIUM 113 110 13 20
AMLODIPINE BESYLATE 106 80 14 4
ATORVASTATIN CALCIUM 101 85 15 8
LOVASTATIN 93 90 16 31
PAROXETINE HCL 92 57 17 63
KLOR-CON M20 92 69 17 45
AZITHROMYCIN 91 55 19 59
GABAPENTIN 91 62 19 16
FINASTERIDE 88 88 21 77
PREDNISONE 88 39 21 27
ALENDRONATE SODIUM 86 83 23 39
TAMSULOSIN HCL 86 82 23 32
ZOLPIDEM TARTRATE 85 63 25 19
CYCLOBENZAPRINE HCL 83 24 R 26 57
FLUOXETINE HCL 83 60 26 52
NEXIUM 78 34 28 28
WARFARIN SODIUM 77 67 29 11
TRAMADOL HCL 75 31 30 24
IBUPROFEN 68 21 31 86
METOPROLOL SUCCINATE 68 64 31 13
RANITIDINE HCL 67 15 33 35
ALLOPURINOL 62 56 34 34
NIFEDIAC CC 61 57 35 191
NIFEDIPINE ER 60 54 36 130
QUETIAPINE FUMARATE 59 17 37 50
TRAZODONE HCL 57 0 38 26
DIOVAN 55 55 39 23
ADVAIR DISKUS 55 48 39 25
HYDROCODONE-ACETAMINOPHEN 53 24 S3 41 18
CYMBALTA 53 24 41 47
AMPHETAMINE SALT COMBO 51 0 S2 43 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.